The Combined Effect of Vulpinic Acid and Doxorubicin in Breast Cancer MCF-7 Cells DOI Open Access
Esma Yeniçeri, Ahmet Altay

Erzincan Üniversitesi Fen Bilimleri Enstitüsü Dergisi, Год журнала: 2024, Номер 17(1), С. 164 - 173

Опубликована: Март 27, 2024

Breast cancer is a major global health problem that imposes significant social and economic burden on individuals societies. Chemotherapy, common treatment approach, often leads to resistance unwanted side effects, especially in the advanced stages of disease. This has led search for more effective less toxic anticancer agents. Lichens, which are associations fungi algae, gaining attention their potential therapy. Lichens rich sources secondary metabolites with diverse biological including anti-tumor properties. In this study, we summarise combined effects vulpinic acid (VA), lichen acid, doxorubicin, chemotherapeutic drug, breast MCF-7 cells. The results XTT assay subsequent Compsyn analysis showed VA doxorubicin (Dox), alone exhibited potent anti-proliferative dose- time-dependent manner, interestingly, when used combination, they produced an antagonistic effect same line. These provide first example study show what combination Dox will have other cell lines.

Язык: Английский

Diffractaic acid exhibits thioredoxin reductase 1 inhibition in lung cancer A549 cells DOI Creative Commons
Şükran Günaydın, Emine Karaca Sulukoğlu, Şeyda Nur Kalın

и другие.

Journal of Applied Toxicology, Год журнала: 2023, Номер 43(11), С. 1676 - 1685

Опубликована: Июнь 17, 2023

Lung cancer is the leading cause of cancer-related deaths all over world. Therefore, it has gained importance in development new chemotherapeutic strategies to identify anticancer agents with low side effects, reliable, high potential, and specific lung cells. Thioredoxin reductase 1 (TrxR1) an important therapeutic target for treatment because its overexpression tumor Here, we aimed examine effect diffractaic acid, a lichen secondary metabolite, A549 cells by comparing commercial drug carboplatin also investigate whether acid occurs via TrxR1-targeting. The IC50 value on was determined as 46.37 μg/mL at 48 h, had stronger cytotoxicity than qPCR results revealed that promoted intrinsic apoptotic pathway through upregulation BAX/BCL2 ratio P53 gene cells, which consistent flow cytometry results. Furthermore, migration analysis indicated impressively suppressed While enzymatic activity TrxR1 inhibited no changes were seen quantitative expression levels protein. These findings provide fundamental data targeting activity, suggesting could be considered agent therapy.

Язык: Английский

Процитировано

6

A new therapeutic strategy for luminal A-breast cancer treatment: vulpinic acid as an anti-neoplastic agent induces ferroptosis and apoptosis mechanisms DOI
Ayşe Hale Alkan, Mine Ensoy, Demet Cansaran‐Duman

и другие.

Medical Oncology, Год журнала: 2024, Номер 41(9)

Опубликована: Авг. 19, 2024

Язык: Английский

Процитировано

1

Lichens in Pharmacological Action: What Happened in the Last Decade? DOI Creative Commons
Yalçın Karagöz, Berna Öztürk

Eurasian Journal of Medicine, Год журнала: 2023, Номер 54(Supp1), С. S195 - S208

Опубликована: Янв. 18, 2023

Lichens are a unique group of organisms, which can produce compounds that named secondary metabolites and rarely or not produced in other organisms. possess pharmacological actions related to their metabolites. Our knowledge lichens rapidly increases as new technologies devices, facilitate the investigation chemical profile biological activities lichens, introduced become more readily available. In addition, methods perspectives, well suggestions for mechanisms, accumulate daily. Furthermore, lichen substances stand relatively untapped source natural products. Accordingly, researchers investigate lichen-derived material frequently than it was past. This review focused on published last 11 years (2012-2022). Literature data obtained from WebOfScience PubMed databases using search keywords revealed anti-genotoxicity, anticancer, anti-microbial activity studies have constantly been conducted. More recently, immunomodulatory inflammation-related took stage. Enzyme inhibition were popular well. selection based novelty mechanistic insight papers presented.

Язык: Английский

Процитировано

3

Antiproliferative, antimigratory, and apoptotic effects of diffractaic and vulpinic acids as thioredoxin reductase 1 inhibitors on cervical cancer DOI

Büşra Budak,

Şeyda Nur Kalın, Ömer Erkan Yapça

и другие.

Naunyn-Schmiedeberg s Archives of Pharmacology, Год журнала: 2023, Номер 397(3), С. 1525 - 1535

Опубликована: Сен. 1, 2023

Язык: Английский

Процитировано

3

Plasma Thioredoxin Reductase as a Potential Biomarker for Gynecologic Cancer DOI Creative Commons
Yinxing Zhu,

Yixuan Hu,

Junfeng Shi

и другие.

Technology in Cancer Research & Treatment, Год журнала: 2023, Номер 22

Опубликована: Янв. 1, 2023

Background According to previous literatures, plasma thioredoxin reductase (TrxR) level was significantly elevated in various malignant tumors and serve as a potential biomarker for diagnosis prognostic prediction. However, there is little awareness of the clinical value TrxR gynecologic malignancies. In present study, we aim evaluate diagnostic accuracy cancer explore its role treatment surveillance. Methods We retrospectively enrolled 134 patients with 79 benign disease. The difference activity tumor markers between two groups compared using Mann-Whitney U test. By detecting pretreatment post-treatment conventional markers, further assessed change trend them Wilcoxon signed-ranks Results Compared control [5.7 (5, 6.6) U/mL], statistically significant increase observed group [8.4 (7.25, 9.825) U/mL] ( P < .0001), regardless age stage. On basis receiver operating characteristic (ROC) curves, found shows highest efficacy distinguishing malignancy disease, an area under curve (AUC) 0.823 (95% confidence interval [CI] = 0.767-0.878), whole cohort. Besides, receiving previously [8 (6.5, 9) had decreased relative treatment-native [9.9 (8.6, 10.85) U/mL]. Furthermore, follow-up data showed that would be evidently after courses antitumor therapy which consistent downward markers. Conclusion Collectively, all these results demonstrated effective parameter concurrently acts promising response assessment.

Язык: Английский

Процитировано

2

Plasma Thioredoxin Reductase as a Potential Diagnostic Biomarker for Breast Cancer DOI

Yixuan Hu,

Yinxing Zhu, Junfeng Shi

и другие.

Clinical Breast Cancer, Год журнала: 2024, Номер 24(6), С. e464 - e473.e3

Опубликована: Март 15, 2024

Язык: Английский

Процитировано

0

The Combined Effect of Vulpinic Acid and Doxorubicin in Breast Cancer MCF-7 Cells DOI Open Access
Esma Yeniçeri, Ahmet Altay

Erzincan Üniversitesi Fen Bilimleri Enstitüsü Dergisi, Год журнала: 2024, Номер 17(1), С. 164 - 173

Опубликована: Март 27, 2024

Breast cancer is a major global health problem that imposes significant social and economic burden on individuals societies. Chemotherapy, common treatment approach, often leads to resistance unwanted side effects, especially in the advanced stages of disease. This has led search for more effective less toxic anticancer agents. Lichens, which are associations fungi algae, gaining attention their potential therapy. Lichens rich sources secondary metabolites with diverse biological including anti-tumor properties. In this study, we summarise combined effects vulpinic acid (VA), lichen acid, doxorubicin, chemotherapeutic drug, breast MCF-7 cells. The results XTT assay subsequent Compsyn analysis showed VA doxorubicin (Dox), alone exhibited potent anti-proliferative dose- time-dependent manner, interestingly, when used combination, they produced an antagonistic effect same line. These provide first example study show what combination Dox will have other cell lines.

Язык: Английский

Процитировано

0